Source: StreetInsider

Press Release: ExcepGen : ExcepGen Emerges From Stealth with New Funding for its Nucleic Acid Therapeutics Platform

SAN FRANCISCO, Aug. 24, 2023 /PRNewswire/ -- ExcepGen, a genetic...

Read full article »
ExcepGen's Competitors | ExcepGen's News | ExcepGen's Financials
Stay up-to-date with the latest news on ExcepGen
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Thomas Folliard's photo - Co-Founder & CEO of ExcepGen

Co-Founder & CEO

Thomas Folliard

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on ExcepGen